Literature DB >> 22677050

Systematic interaction analysis of human lipocalin-type prostaglandin D synthase with small lipophilic ligands.

Satoshi Kume1, Young-Ho Lee, Yuya Miyamoto, Harumi Fukada, Yuji Goto, Takashi Inui.   

Abstract

L-PGDS [lipocalin-type PG (prostaglandin) D synthase] is a multi-functional protein, acting as a PGD₂-producing enzyme and a lipid-transporter. In the present study, we focus on the function of L-PGDS as an extracellular transporter for small lipophilic molecules. We characterize the binding mechanism of human L-PGDS for the molecules, especially binding affinity stoichiometry and driving force, using tryptophan fluorescence quenching, ICD (induced circular dichroism) and ITC (isothermal titration calorimetry). The tryptophan fluorescence quenching measurements revealed that haem metabolites such as haemin, biliverdin and bilirubin bind to L-PGDS with significantly higher affinities than the other small lipophilic ligands examined, showing dissociation constant (K(d)) values from 17.0 to 20.9 nM. We focused particularly on the extra-specificities of haem metabolites and L-PGDS. The ITC and ICD data revealed that two molecules of the haem metabolites bind to L-PGDS with high and low affinities, showing K(d) values from 2.8 to 18.1 nM and from 0.209 to 1.63 μM respectively. The thermodynamic parameters for the interactions revealed that the contributions of enthalpy and entropy change were considerably different for each haem metabolite even when the Gibbs energy change was the same. Thus we believe that the binding energy of haem metabolites to L-PGDS is optimized by balancing enthalpy and entropy change.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22677050     DOI: 10.1042/BJ20120324

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  7 in total

Review 1.  Biophysical Approaches for the Characterization of Protein-Metabolite Interactions.

Authors:  Anja Thalhammer; Nina K Bröker
Journal:  Methods Mol Biol       Date:  2023

2.  Structural and dynamic insights into substrate binding and catalysis of human lipocalin prostaglandin D synthase.

Authors:  Sing Mei Lim; Dan Chen; Hsiangling Teo; Annette Roos; Anna Elisabet Jansson; Tomas Nyman; Lionel Trésaugues; Konstantin Pervushin; Pär Nordlund
Journal:  J Lipid Res       Date:  2013-03-22       Impact factor: 5.922

3.  Lipocalin-type prostaglandin D synthase scavenges biliverdin in the cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage.

Authors:  Takashi Inui; Mitsuhito Mase; Ryoko Shirota; Mariko Nagashima; Tetsuya Okada; Yoshihiro Urade
Journal:  J Cereb Blood Flow Metab       Date:  2014-07-09       Impact factor: 6.200

4.  Anticholinergic Drugs Interact With Neuroprotective Chaperone L-PGDS and Modulate Cytotoxicity of Aβ Amyloids.

Authors:  Kimberly Jia Yi Low; Margaret Phillips; Konstantin Pervushin
Journal:  Front Pharmacol       Date:  2020-06-11       Impact factor: 5.810

5.  Amyloid β chaperone - lipocalin-type prostaglandin D synthase acts as a peroxidase in the presence of heme.

Authors:  Margaret Phillips; Bhuvaneswari Kannaian; Justin Ng Tze Yang; Ralf Kather; Mu Yuguang; Jeffrey R Harmer; Konstantin Pervushin
Journal:  Biochem J       Date:  2020-04-17       Impact factor: 3.857

6.  Interaction of multimicrobial synthetic inhibitor 1,2-bis(2-benzimidazolyl)-1,2-ethanediol with serum albumin: spectroscopic and computational studies.

Authors:  Nayana Kamtekar; Anita Pandey; Neeraj Agrawal; Raghuvir R S Pissurlenkar; Mohanish Borana; Basir Ahmad
Journal:  PLoS One       Date:  2013-01-04       Impact factor: 3.240

7.  Human Lipocalin-Type Prostaglandin D Synthase-Based Drug Delivery System for Poorly Water-Soluble Anti-Cancer Drug SN-38.

Authors:  Masatoshi Nakatsuji; Haruka Inoue; Masaki Kohno; Mayu Saito; Syogo Tsuge; Shota Shimizu; Atsuko Ishida; Osamu Ishibashi; Takashi Inui
Journal:  PLoS One       Date:  2015-11-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.